Analysts forecast that the obesity drug market may be worth $105 billion in 2030 and could reach as high as $144 billion.
Semaglutide was approved for medical use in the US in 2017, and its indications have expanded over the years to include not just type 2 diabetes management but also long-term weight management for adults with obesity or who are overweight and have at least one weight-related comorbidity [20]
However, a handful of statesincluding California, Illinois, and New Yorkhave specific limits on the number of needles you can buy without a prescription, or they may require the pharmacist to keep a record of the sale
Knowledge of how they work and how they integrate into the Indian way of life can inform rational decisions
Nutritional counseling, often available at med spas offering semaglutide weight loss programs, can provide personalized dietary advice, ensuring your eating habits support your weight loss goals